Unauthorized promotion to the general public is one of the highest risks when using social media, says a new guidance from the drug industry associations IFPMA and EFPIA.
Engaging with online influencers requires subtle and careful evaluation, says new guidance from industry on how drug companies can manage the risks involved with social media and digital channels and avoid unauthorized promotion to the general public.
In addition, companies should be aware that they are responsible for all content disseminated via a digital channel including social...
Create an account to read this article
Already a subscriber?
Complaint names LillyDirect in action targeting the company’s free nurse and reimbursement support programs for health care providers.
The Council of the EU has not taken forward a proposal from the European Parliament that would require companies to disclose the transfers of value they make to health care professionals and health care organizations – lawyers weigh in on the diverging proposals.
Lawyers explain how changes to rules around drug advertising and promotional activities under the EU pharma reform package could impact companies operating in the bloc, with one legal expert advising companies to “monitor developments closely.”
Cindy Eckert’s social media post with a People.com story failed to include any risk information, made misleading representations about benefits and omitted material information about the indication, said the agency, which flagged similar concerns about an Addyi radio ad five years ago.
Compliance deadline comes three months after manufacturers were required to start sending accurate, electronic product tracking data to distributors. The Healthcare Distribution Alliance said its members are ready and it does not anticipate major supply chain issues.
ISRCTN says its new system for reporting clinical trial results summaries will simplify compliance, and includes features to reduce data entry errors, improve accuracy, enhance accessibility and the reuse of trial results.
Complaint names LillyDirect in action targeting the company’s free nurse and reimbursement support programs for health care providers.
